Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04353401 · ClinicalTrials.gov registry record
WGS Analysis of COVID-19 Positive Patients
A clinical trial of COVID-19 and Corona Virus Infection, sponsored by Vanda Pharmaceuticals.
- Completed
- Registry status
- 79
- Enrollment target
- 1
- Study location
NCT04353401: Completed study of COVID-19 and Corona Virus Infection, sponsored by Vanda Pharmaceuticals.
NCT04353401 is a study of COVID-19 and Corona Virus Infection that has completed, run by Vanda Pharmaceuticals. The registered enrollment target is 79 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04353401, a study of COVID-19 and Corona Virus Infection, has completed, sponsored by Vanda Pharmaceuticals.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.
Primary Outcome
Clinical associations with human and viral genetics
Conditions Studied
Study Locations (1)
Ohio
- Vanda Investigational Site - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2022-03-09 |
What the finished NCT04353401 record still lists
NCT04353401 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.
NCT04353401 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04353401 about?
NCT04353401 is a clinical study titled "WGS Analysis of COVID-19 Positive Patients". We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.
What is the current status of trial NCT04353401?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2020-08-03. Estimated completion is 2022-03-09.
What conditions does trial NCT04353401 study?
This clinical trial studies the following conditions: COVID-19, Corona Virus Infection.
Who is sponsoring clinical trial NCT04353401?
This trial is sponsored by Vanda Pharmaceuticals, which has 68 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04353401 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04353401's enrollment target sits among peer trials
79 222nd of 298 higher than 77 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI